Dialysis services provider Nephrocare Health Services, which operates the NephroPlus brand, will open its ₹871.05 crore IPO on December 10. The issue will close on December 12, with anchor bidding scheduled for December 9.

The company has set a price band of ₹438 to ₹460. Investors can apply for a minimum of 32 shares and in multiples thereafter.

Nephrocare plans to raise ₹353.4 crore through a fresh issue, while promoters and existing investors will sell up to 1.12 crore equity shares through an offer for sale. Investcorp, Healthcare Parent, Edoras Investment Holdings, International Finance Corporation and 360 ONE are among the sellers in the OFS.

Promoters currently hold 78.9% in NephroPlus, and the remaining 21.1% is owned by public shareholders including IFC and 360 ONE.

From the f

See Full Page